Isotope ratio mass spectrometry analysis of the oxidation products of the main and minor metabolites of hydrocortisone and cortisone for antidoping controls

Abstract

Metabolites of hydrocortisone (HC) and cortisone (C), namely tetrahydrocortisol (THF), tetrahydrocortisone (THE), allo-THF, allo-THE for the main metabolites and 11-hydroxyandrosterone, 11-hydoxyetiocholanolone, 11-ketoandrosterone, and 11-ketoetiocholanolone for the minor metabolites, as well as the two main metabolites of testosterone, androsterone and etiocholanolone, were separated from each other using HPLC fractionation of urine extracts. An isotopic ratio mass spectrometry (IRMS) analysis determined the absolute δ 13C values of 5α-androstanetrione (5α-AT) and 5β-androstanetrione (5β-AT) as the oxidation products (ox-products) of the HC and C metabolites and as target compounds (TCs). We also performed IRMS analysis of 5α-androstanedione (5α-AD) and 5β-androstanedione (5β-AD) as the ox-products of etiocholanolone and androsterone and as endogenous reference compounds (ERCs). Urine samples came from two male volunteers treated with a single 10-mg oral dose and a single 100-mg intramuscular dose of HC hemisuccinate, a male volunteer treated with a single 25-mg oral dose of C acetate, and a control group of 30 drug-free athletes. The mean −3SD of δ 13C depletion values from the controls were −1.46, −1.98, −1.78 and −2.42 for 5β-AT–5β-AD, 5α-AT–5β-AD, 5β-AT–5α-AD and 5α-AT–5α-AD, respectively, indicating −3‰ as a safe cut-off value for differentiating the pharmaceutical from the natural form. In the main metabolite fraction, δ 13C depletion values peaked around −5‰ and −9‰ after oral and intramuscular administration of HC, respectively, and around −6‰ after oral administration of C. In comparison, less impressive results were obtained when IRMS analysis focused on the ox-products of the minor metabolites.